Skip to main content

AstraZeneca receives $1 billion in US funding for Oxford University coronavirus vaccine

AstraZeneca has agreed to initially supply at least 400 million doses of Oxford University's coronavirus vaccine and secured total manufacturing capacity to produce 1 billion doses.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.